magnesium sulfate has been researched along with Acute Brain Injuries in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 7 (14.29) | 18.2507 |
| 2000's | 21 (42.86) | 29.6817 |
| 2010's | 17 (34.69) | 24.3611 |
| 2020's | 3 (6.12) | 2.80 |
| Authors | Studies |
|---|---|
| André, C; Curioni, CC; da Silva, ACF; de Velasco, PC; Lamarca, F; Mocellin, MC; Ribas, SA; Tavares, MDS | 1 |
| Beloosesky, R; Ben David, C; Ginsberg, Y; Khatib, N; Ross, MG; Vitner, D; Weiner, Z; Zamora, O; Zipori, Y | 1 |
| Asci, H; Ozmen, O; Savran, M; Sezik, M; Yalcin, SE; Yavuz, A | 1 |
| Arison, S; Beloosesky, R; Ginsberg, Y; Khatib, N; Ross, MG; Weiner, Z; Weiss, B | 1 |
| Chen, N; Feng, SC; Tu, Y; Wang, LL; Xu, RJ; Zhang, M; Zhou, JY | 1 |
| Cleren, C; Daher, I; Dourmap, N; Dupré, N; Gonzalez, BJ; Le Dieu-Lugon, B; Lecointre, M; Leroux, P; Leroux-Nicollet, I; Marret, S; Voisin, C | 1 |
| Bagheri, G; Bagheri, S; Docea, AO; Hashemzaei, M; Jahantigh, H; Moghadam, AA; Rezaee, R; Shahraki, J; Shahriari, M; Spandidos, DA; Tabrizian, K; Tsarouhas, K; Tsatsakis, A; Wilks, MF | 1 |
| Bain, E; Crowther, CA; Nguyen, TM; Wilkinson, D | 1 |
| Aksu, I; Arda, MN; Baykara, B; Cetin, F; Dayi, A; Gurpinar, T; Kiray, M; Ozdemir, D; Uysal, N | 1 |
| Belozertsev, FIu; Belozertsev, IuA; Iuntsev, SV; Zapol'skaia, IuA | 1 |
| Ashwood, PJ; Bain, ES; Crowther, CA; Middleton, PF; Yelland, LN | 1 |
| Bai, YA; Li, W; Li, YF; Li, YJ; Liu, KG; Shang, HL; Wang, MD; Xu, GZ | 1 |
| Amirjamshidi, A; Ashouri, A; Ketabchi, E; Khajavi, M; Mirrahimi, B; Mojtahedzadeh, M; Mortazavi, A; Nouri, M | 1 |
| Andersen, CC; Hodyl, NA; Stark, MJ | 1 |
| Anblagan, D; Bastin, ME; Boardman, JP; Clayden, JD; Moore, EJ; Pataky, R; Piyasena, C; Semple, SI; Serag, A; Sparrow, S; Wilkinson, AG | 1 |
| Berger, VK; Chock, VY; Davis, AS | 1 |
| Iams, JD | 1 |
| Breen, K; Burd, I; Chai, J; Elovitz, MA; Friedman, A | 1 |
| Dede, H; Gelisen, O; Secilmis, O; Solaroglu, A; Suat Dede, F | 1 |
| Bloch-Shilderman, E; Brandeis, R; Egoz, I; Grauer, E; Katalan, S; Lazar, S; Rabinovitz, I; Raveh, L | 1 |
| Dai, W; Deng, X; Xu, M | 1 |
| Heath, DL; Nimmo, AJ; O'Connor, CA; Vink, R | 1 |
| Browne, KD; Chen, XH; Iwata, A; Leoni, MJ; Smith, DH | 1 |
| Golan, H; Hallak, M; Huleihel, M; Kashtuzki, I; Sorokin, Y | 1 |
| Fromm, L; Heath, DL; Nimmo, AJ; Vink, R | 1 |
| Dasilva, KW; O'Connor, C; Turner, RJ; van den Heuvel, C; Vink, R | 1 |
| Borel, CO; Brewer, RP; Campbell, KA; Macy, GE; McKee, JA; Phillips-Bute, B; Reynolds, JD; Warner, DS | 1 |
| Aruga, T; Dohi, K; Ohtaki, H; Shioda, S | 1 |
| Gerstein, M; Golan, H; Hallak, M; Huleihel, M; Kashtuzki, I; Mane, R; Stilman, M | 1 |
| Borel, CO; Brewer, RP; Macy, GE; McKee, JA; Reynolds, JD; Warner, DS | 1 |
| Maas, AI; Murray, GD | 1 |
| Anderson, GD; Barber, J; Britz, GW; Dikmen, SS; Ellenbogen, RG; Lucas, T; Machamer, JE; Mansfield, PN; Newell, DW; Schuster, J; Temkin, NR; Winn, HR | 1 |
| Christensen, J; Guerguerian, AM; Johnston, MV; Joseph, JG; McCarter, R; Natale, JE; Shaffner, DH; Shao, C; Slomine, B | 1 |
| Duhaime, AC | 1 |
| Carson-Walter, EB; Dixon, CE; Fischer, MR; Puccio, AM; Stippler, M; Walter, KA; Wisniewski, SR | 1 |
| Beskonakli, E; Bodur, E; Eroglu, H; Okutan, O; Oner, L; Sargon, MF; Tun, MK; Turkoglu, OF | 1 |
| Bågenholm, R; Kjellmer, I; Thiringer, K; Thordstein, M | 1 |
| Faden, AI | 1 |
| Perlman, JM | 1 |
| Galvin, KA; Oorschot, DE | 1 |
| Heath, DL; Vink, R | 3 |
| Ikenoue, T; Ota, A; Sameshima, H | 1 |
| Blumbergs, PC; Finnie, JW; Jones, NR; Manavis, J; Pereira, RA; Reilly, PL; Van Den Heuvel, C | 1 |
| Oorschot, DE | 1 |
| Ak, A; Duman, A; Gürbilek, M; Ustün, ME; Vatansev, H | 1 |
| Ak, A; Duman, A; Oğun, CO; Ustün, ME; Vatansev, H | 1 |
| Faden, AI; McIntosh, TK; Vink, R; Yamakami, I | 1 |
7 review(s) available for magnesium sulfate and Acute Brain Injuries
| Article | Year |
|---|---|
Effectiveness of nutritional interventions to prevent nonprogressive congenital and perinatal brain injuries: a systematic review and meta-analysis of randomized trials.
Topics: Acetylcysteine; Brain Injuries; Cerebral Palsy; Child; Choline; Docosahexaenoic Acids; Female; Fetal Alcohol Spectrum Disorders; Humans; Infant; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Pregnancy; Randomized Controlled Trials as Topic; Uridine Monophosphate; Vitamin A; Vitamin D | 2022 |
Magnesium sulphate for women at term for neuroprotection of the fetus.
Topics: Brain Injuries; Cerebral Palsy; Female; Fetus; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic | 2013 |
Magnesium sulfate for acute traumatic brain injury.
Topics: Brain Injuries; Cause of Death; Glasgow Coma Scale; Glasgow Outcome Scale; Humans; Magnesium Sulfate; Neuroprotective Agents; Survival Rate | 2015 |
Perinatal Neuroprotection for Extremely Preterm Infants.
Topics: Adrenal Cortex Hormones; Brain Injuries; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Magnesium Sulfate; Neuroprotection; Parturition; Postnatal Care; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2016 |
Magnesium neuroprotection is limited in humans with acute brain injury.
Topics: Brain Injuries; Brain Ischemia; Eclampsia; Female; Homeostasis; Humans; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Subarachnoid Hemorrhage | 2005 |
Antenatal glucocorticoid, magnesium exposure, and the prevention of brain injury of prematurity.
Topics: Brain; Brain Injuries; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Prenatal Care | 1998 |
Cerebral palsy and experimental hypoxia-induced perinatal brain injury: is magnesium protective?
Topics: Animals; Brain Injuries; Cerebral Palsy; Female; Humans; Hypoxia; Hypoxia-Ischemia, Brain; Magnesium; Magnesium Chloride; Magnesium Sulfate; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Rats; Sheep | 2000 |
6 trial(s) available for magnesium sulfate and Acute Brain Injuries
| Article | Year |
|---|---|
Magnesium sulphate neuroprotection mechanism is placental mediated by inhibition of inflammation, apoptosis and oxidative stress.
Topics: Animals; Apoptosis; Brain Injuries; Caspase 3; Female; Inflammation; Interleukin-6; Lipopolysaccharides; Magnesium Sulfate; Neuroprotection; Oxidative Stress; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2022 |
Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.
Topics: Blood Pressure; Brain Injuries; Cerebral Hemorrhage; Cerebral Palsy; Cesarean Section; Diastole; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Respiratory Rate | 2014 |
Effect of magnesium on functional outcome and paraclinical parameters of patients undergoing supratentorial craniotomy for brain tumors: a randomized controlled trial.
Topics: Adult; Brain Injuries; Brain Neoplasms; Craniotomy; Double-Blind Method; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Phosphopyruvate Hydratase; S100 Calcium Binding Protein beta Subunit; Treatment Outcome | 2015 |
Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Availability; Brain; Brain Injuries; Female; Humans; Infusions, Intravenous; Magnesium; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents | 2005 |
Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Brain Injuries; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glasgow Coma Scale; Humans; Magnesium; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Pulmonary Edema; Respiratory Insufficiency; Seizures; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
Topics: Adolescent; Blood Pressure; Brain Injuries; Cerebrovascular Circulation; Child; Child, Preschool; Data Interpretation, Statistical; Double-Blind Method; Electrocardiography; Feasibility Studies; Female; Heart Conduction System; Humans; Infusions, Intravenous; Intracranial Pressure; Magnesium Sulfate; Male; Neuroprotective Agents; Patient Selection; Pilot Projects; Placebos; Safety; Time Factors | 2007 |
36 other study(ies) available for magnesium sulfate and Acute Brain Injuries
| Article | Year |
|---|---|
Combined Use of Magnesium Sulfate and Fingolimod for Antenatal Neuroprotection against Inflammation-Mediated Experimental Preterm Brain Injury in a Rat Model.
Topics: Animals; Brain Injuries; Endotoxins; Female; Fingolimod Hydrochloride; Humans; Inflammation; Interleukin-10; Interleukin-6; Magnesium Sulfate; Neuroprotection; Neuroprotective Agents; Pregnancy; Rats | 2022 |
Magnesium sulfate (MG) prevents maternal inflammation induced offspring cerebral injury evident on MRI but not via IL-1β.
Topics: Animals; Animals, Newborn; Brain Injuries; Female; Fetus; Inflammation; Interleukin-1beta; Lipopolysaccharides; Magnesium Sulfate; Magnetic Resonance Imaging; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley | 2017 |
Protective Effects of Magnesium Sulfate on Radiation Induced Brain Injury in Rats.
Topics: Animals; Apoptosis; Brain; Brain Injuries; Calcium; Caspase 3; Female; Intercellular Adhesion Molecule-1; Magnesium; Magnesium Sulfate; Male; Malondialdehyde; Neurons; NF-kappa B; Oxidative Stress; Radiation Injuries; Radiation-Protective Agents; Rats, Sprague-Dawley; RNA, Messenger | 2018 |
Time- and sex-dependent efficacy of magnesium sulfate to prevent behavioral impairments and cerebral damage in a mouse model of cerebral palsy.
Topics: Animals; Animals, Newborn; Anticonvulsants; Brain Injuries; Cerebral Palsy; Disease Models, Animal; Female; Magnesium Sulfate; Male; Mice; Reflex, Righting; Sex Characteristics; Sex Factors; Time Factors; Treatment Outcome | 2018 |
Magnesium sulfate ameliorates carbon monoxide‑induced cerebral injury in male rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Injuries; Carbon Monoxide; Carbon Monoxide Poisoning; Dose-Response Relationship, Drug; Gene Expression Regulation; Injections, Intraperitoneal; Magnesium Sulfate; Male; Malondialdehyde; Necrosis; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction | 2019 |
Combined treatment with progesterone and magnesium sulfate positively affects traumatic brain injury in immature rats.
Topics: Animals; Anxiety; Apoptosis; Brain; Brain Injuries; DNA Fragmentation; Magnesium Sulfate; Maze Learning; Memory; Neuroprotective Agents; Progesterone; Rats; Rats, Wistar | 2013 |
[Comparison of neuroprotective effects of anticonvulsant drugs in brain injury therapy].
Topics: Amines; Animals; Animals, Outbred Strains; Anticonvulsants; Brain; Brain Injuries; Brain Ischemia; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Electric Stimulation; Fructose; Gabapentin; gamma-Aminobutyric Acid; Lamotrigine; Magnesium Sulfate; Mice; Rats; Seizures; Topiramate; Triazines; Valproic Acid | 2012 |
Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.
Topics: Brain; Brain Injuries; Carotid Arteries; Cerebrovascular Circulation; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Kinetics; Magnesium Sulfate; Male; Maternal Exposure; Neuroprotective Agents; Oxygen; Oxygen Consumption; Pregnancy; Prenatal Care; Spectroscopy, Near-Infrared; Tocolytic Agents | 2015 |
Tract shape modeling detects changes associated with preterm birth and neuroprotective treatment effects.
Topics: Biomarkers; Brain Injuries; Diffusion Magnetic Resonance Imaging; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Magnesium Sulfate; Male; Neural Pathways; Neuroprotective Agents; White Matter | 2015 |
Latest research from the 2010 meeting of the Society for Maternal-Fetal Medicine.
Topics: Animals; Blood Glucose; Brain Injuries; Cesarean Section; Congresses as Topic; Female; Genetic Testing; Gestational Age; Heterozygote; Humans; Inflammation; Labor, Induced; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Research; Societies, Medical; Spinal Muscular Atrophies of Childhood; Tocolytic Agents | 2010 |
Magnesium sulfate reduces inflammation-associated brain injury in fetal mice.
Topics: Animals; Brain; Brain Injuries; Caspases; Cell Count; Cells, Cultured; Cytokines; Dendritic Cells; Female; Fetus; Glial Fibrillary Acidic Protein; Inflammation; Injections, Intraperitoneal; Intermediate Filament Proteins; Lipopolysaccharides; Magnesium Sulfate; Mice; Microtubule-Associated Proteins; Models, Animal; Nerve Tissue Proteins; Nestin; Neurons; Polymerase Chain Reaction; Pregnancy; Random Allocation; RNA, Messenger; Tocolytic Agents | 2010 |
Neuroprotective effect of magnesium sulfate treatment on fetal brain in experimental intrauterine ischemia reperfusion injury.
Topics: Animals; Anticonvulsants; Brain Injuries; Brain Ischemia; Drug Evaluation, Preclinical; Female; Fetal Diseases; Magnesium Sulfate; Pregnancy; Rats; Rats, Wistar; Reperfusion Injury | 2011 |
Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity.
Topics: Animals; Anticonvulsants; Antidotes; Brain Injuries; Cerebral Cortex; Chemical Warfare Agents; Cyclopentanes; Epilepsy, Tonic-Clonic; Magnesium Sulfate; Male; Midazolam; Rats; Rats, Sprague-Dawley; Sarin; Seizures; Telemetry | 2013 |
Effects of magnesium sulfate on brain mitochondrial respiratory function in rats after experimental traumatic brain injury.
Topics: Animals; Brain Injuries; Cell Respiration; Culture Techniques; Disease Models, Animal; Hypoxia-Ischemia, Brain; Magnesium Sulfate; Male; Mitochondria; Oxygen Consumption; Random Allocation; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity | 2002 |
Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats.
Topics: Animals; Brain Injuries; Cognition; Disease Models, Animal; Magnesium Sulfate; Male; Maze Learning; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
Acute treatment with MgSO4 attenuates long-term hippocampal tissue loss after brain trauma in the rat.
Topics: Animals; Brain Injuries; Cell Count; Hippocampus; Magnesium Sulfate; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Time | 2004 |
Maternal hypoxia during pregnancy induces fetal neurodevelopmental brain damage: partial protection by magnesium sulfate.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Ataxia; Behavior, Animal; Brain; Brain Injuries; Brain-Derived Neurotrophic Factor; Cell Count; Enzyme-Linked Immunosorbent Assay; Female; Hypoxia; Magnesium Sulfate; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Nerve Growth Factor; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Spatial Behavior | 2004 |
Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats.
Topics: Animals; Brain Injuries; Depression; Disease Models, Animal; Magnesium; Magnesium Sulfate; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Time Factors; Treatment Outcome | 2004 |
Magnesium gluconate offers no more protection than magnesium sulphate following diffuse traumatic brain injury in rats.
Topics: Animals; Brain; Brain Injuries; Cognition; Gluconates; Magnesium; Magnesium Sulfate; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Treatment Outcome | 2004 |
Magnesium sulfate therapy in patients with acute neuronal damage: The problem of intravenous administration.
Topics: Biological Availability; Brain; Brain Injuries; Humans; Infusions, Intravenous; Magnesium; Magnesium Sulfate; Neuroprotective Agents | 2005 |
Remodeling of hippocampal GABAergic system in adult offspring after maternal hypoxia and magnesium sulfate load: immunohistochemical study.
Topics: Animals; Brain Injuries; Calbindins; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hippocampus; Hypoxia, Brain; Immunohistochemistry; Magnesium Sulfate; Mice; Neurons; Neuroprotective Agents; Parvalbumins; Pregnancy; Prenatal Exposure Delayed Effects; S100 Calcium Binding Protein G; Vesicular Inhibitory Amino Acid Transport Proteins | 2005 |
Magnesium for neuroprotection after traumatic brain injury.
Topics: Brain Chemistry; Brain Injuries; Glasgow Coma Scale; Humans; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Treatment Outcome | 2007 |
Why are clinical trials in pediatric head injury so difficult?
Topics: Age Factors; Animals; Brain Injuries; Child; Clinical Trials as Topic; Craniocerebral Trauma; Disease Models, Animal; Feasibility Studies; Humans; Magnesium Sulfate; Neuroprotective Agents; Pilot Projects; Rodentia | 2007 |
Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain Injuries; Cohort Studies; Databases, Factual; Female; Glasgow Coma Scale; Humans; Magnesium; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2007 |
A comparative study of treatment for brain edema: magnesium sulphate versus dexamethasone sodium phosphate.
Topics: Animals; Brain; Brain Edema; Brain Injuries; Dexamethasone; Disease Models, Animal; Female; Lipid Peroxidation; Magnesium Sulfate; Microscopy, Electron, Transmission; Neuroprotective Agents; Organ Size; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2008 |
Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat.
Topics: Animals; Animals, Newborn; Brain Injuries; Brain Ischemia; Female; Free Radical Scavengers; Hypoxia, Brain; Magnesium Sulfate; Male; Pregnancy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Time Factors | 1993 |
Comparison of single and combination drug treatment strategies in experimental brain trauma.
Topics: Animals; Azetidines; Behavior, Animal; Brain Injuries; Dextrorphan; Dipeptides; Drug Therapy, Combination; Forelimb; Magnesium Sulfate; Male; Movement; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley | 1993 |
Postinjury magnesium sulfate treatment is not markedly neuroprotective for striatal medium spiny neurons after perinatal hypoxia/ischemia in the rat.
Topics: Animals; Brain Injuries; Brain Ischemia; Cerebral Palsy; Corpus Striatum; Female; Magnesium Sulfate; Neurons; Oxygen; Pregnancy; Rats; Rats, Sprague-Dawley | 1998 |
Optimization of magnesium therapy after severe diffuse axonal brain injury in rats.
Topics: Animals; Brain; Brain Injuries; Dose-Response Relationship, Drug; Magnesium Chloride; Magnesium Compounds; Magnesium Sulfate; Magnetic Resonance Spectroscopy; Male; Neurologic Examination; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |
Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats.
Topics: Animals; Axons; Brain Injuries; Drug Administration Schedule; Magnesium Sulfate; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 1999 |
Pretreatment with magnesium sulfate protects against hypoxic-ischemic brain injury but postasphyxial treatment worsens brain damage in seven-day-old rats.
Topics: Animals; Animals, Newborn; Anticonvulsants; Brain Injuries; Drug Administration Schedule; Hypoxia, Brain; Injections, Intraperitoneal; Magnesium Sulfate; Neuroprotective Agents; Premedication; Rats; Rats, Wistar | 1999 |
Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in traumatic brain injury.
Topics: Amyloid beta-Protein Precursor; Animals; Blotting, Northern; Brain Injuries; Female; In Situ Hybridization; Magnesium Sulfate; Neurons; Sheep; Up-Regulation | 2000 |
Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma.
Topics: Analysis of Variance; Animals; Brain; Brain Injuries; Female; Lactic Acid; Lipid Peroxidation; Magnesium Sulfate; Male; Malondialdehyde; Prospective Studies; Rabbits; Random Allocation | 2001 |
Subdural hematoma following traumatic brain injury causes a secondary decline in brain free magnesium concentration.
Topics: Animals; Brain; Brain Injuries; Hematoma, Subdural; Magnesium; Magnesium Sulfate; Male; Motor Activity; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Wounds, Nonpenetrating | 2001 |
Effects of nimodipine and magnesium sulfate on endogenous antioxidant levels in brain tissue after experimental head trauma.
Topics: Analysis of Variance; Animals; Antioxidants; Blood Pressure; Brain; Brain Injuries; Carbon Dioxide; Cerebral Cortex; Craniocerebral Trauma; Craniotomy; Female; Functional Laterality; Glutathione Peroxidase; Heart Rate; Ketamine; Magnesium Sulfate; Male; Nimodipine; Oxygen; Partial Pressure; Rabbits; Superoxide Dismutase; Time Factors | 2001 |
Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies.
Topics: Animals; Blood Gas Analysis; Blood Pressure; Brain Injuries; Magnesium Deficiency; Magnesium Sulfate; Magnetic Resonance Spectroscopy; Male; Phosphorus; Rats; Time Factors | 1988 |